文献速递传染病防控与疫情报告妇幼与学校卫生卫生政策与健康促进

婴儿期巨细胞病毒感染与儿童结核病风险:南非开普敦纵向出生队列研究

Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa.
PubMed 文献 · Lancet Glob Health · 2021-01-01

该前瞻性出生队列在南非开普敦招募孕妇并随访其子女至9岁,发现婴儿期获得巨细胞病毒感染与1岁后结核病风险升高相关, adjusting后HR最高达4.2(95%CI 2.0-8.8),作者认为高负担国家或需考虑预防或延迟围产期及生后早期巨细胞病毒感染。

要点

  • 6周龄时巨细胞病毒阳性者1岁后结核病风险升高(调整HR 4.1,95%CI 1.2-13.8)。
  • 24月龄时巨细胞病毒阳性者结核病风险升高(调整HR 4.2,95%CI 2.0-8.8)。
  • 3月龄前高巨细胞病毒载量者结核病风险高于低载量者(调整HR 3.7 vs 2.0,趋势P=0.0020)。

核心结论

  • 婴儿期第一年内获得巨细胞病毒感染与随后发生结核病风险升高相关。
  • 作者认为高负担国家预防幼儿结核病的努力或需考虑阻止或延迟围产期及生后数月内巨细胞病毒感染的获得。

研究设计与样本

  • 前瞻性出生队列研究,在南非开普敦郊区Paarl的两家诊所(TC Newman和Mbekweni)招募妊娠20至28周的孕妇。
  • 2012年3月5日至2015年3月31日招募1225名孕妇,排除88名(7%)因产前失访或妊娠丢失,1143例活产中排除68对(6%)母婴,共963名儿童接受巨细胞病毒系列检测(7186次检测,每名儿童中位6次,IQR 2-11)。
  • 婴儿出生时按国家政策接种卡介苗,出生时、3周、6周、3月、6月、12月、24月龄采集鼻咽拭子用qPCR检测巨细胞病毒。
  • 儿童前瞻性随访至9岁,采用结核菌素皮肤试验、影像学检查、GeneXpert和痰检诊断结核病;结核菌素皮肤试验在6月龄及12、24、36、48、60月龄和下呼吸道感染时进行。
  • 采用Cox回归和风险比(HR)及95%CI比较有和无巨细胞病毒感染儿童1岁后或6月龄后结核病发病率。

主要发现

  • 3周龄以下先天性巨细胞病毒患病率为2%(18/816)。
  • 巨细胞病毒阳性率随年龄持续上升:6周龄3%(27/825),3月龄21%(183/882),6月龄35%(315/909),12月龄42%(390/933)。
  • 母婴对中位随访6.9年(IQR 6.0-7.8)。
  • 1岁后结核病风险在6周龄(调整HR 4.1,95%CI 1.2-13.8;P=0.022)、3月龄(2.8,1.4-5.8;P=0.0040)、6月龄(3.6,1.7-7.3;P<0.0001)、12月龄(3.2,1.6-6.4;P=0.0010)和24月龄(4.2,2.0-8.8;P<0.0001)巨细胞病毒感染者中更高。
  • 微生物学确诊结核病风险在3月龄前(调整HR 3.2,95%CI 1.0-10.6;P=0.048)、6月龄(3.9,1.2-13.0;P=0.027)、12月龄(4.4,1.2-16.3;P=0.027)和24月龄(6.1,1.3-27.9;P=0.020)获得巨细胞病毒感染者中更高。

关键数值与推荐

  • 6周龄巨细胞病毒阳性者1岁后结核病调整HR 4.1(95%CI 1.2-13.8;P=0.022)。
  • 3月龄巨细胞病毒阳性者1岁后结核病调整HR 2.8(95%CI 1.4-5.8;P=0.0040)。
  • 6月龄巨细胞病毒阳性者1岁后结核病调整HR 3.6(95%CI 1.7-7.3;P<0.0001)。
  • 12月龄巨细胞病毒阳性者1岁后结核病调整HR 3.2(95%CI 1.6-6.4;P=0.0010)。
  • 24月龄巨细胞病毒阳性者1岁后结核病调整HR 4.2(95%CI 2.0-8.8;P<0.0001)。

临床怎么用

  • 作者认为高负担国家预防幼儿结核病的努力或需考虑阻止或延迟围产期及生后数月内巨细胞病毒感染的获得。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. METHODS: In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. FINDINGS: Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). INTERPRETATION: Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. FUNDING: Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Martinez L, Nicol MP, Wedderburn CJ, et al. Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa. Lancet Glob Health. 2021. PMID: 34798032. doi:10.1016/S2214-109X(21)00407-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。